Yogish C. Kudva MBBS
Professor, Internal Medicine and Endocrinology/Diabetes, Mayo Clinic College of Medicine; Fellowship Consultant, Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MinnesotaDisclosures
Dr. Kudva has received product support from tandem through the Jaeb Center, Tampa, Florida, for conduct of the International Diabetes Closed Loop trial (IDCL, NCT03563313). He has also received product support from Dexcom Inc and Roche Diabetes. His research has been supported by NIDDK, JDRF International and Helmsley Charitable Trust.
Recent Contributions to PracticeUpdate:
- Therapy Settings Associated With Optimal Outcomes for t:slim X2 With Control-IQ Technology in Real-World Clinical Care
- Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
- Efficacy and Safety of Tandem Control-IQ Without User-Initiated Boluses in Adults With Uncontrolled Type 1 Diabetes
- Glycaemic Outcomes Following Insulin Pump Therapy Initiation in People With T1D
- MiniMed Advanced Hybrid Closed-Loop System for T1D
- Reduced Albuminuria in T1D Treated With Sensor-Augmented Insulin Pump and Improved Time in Range Over 1 Year
- Switching Insulin Delivery System Improves Glucose Control and Reduces Glucose Variability